Panacea Life Sciences Holdings, Inc. Convertible Notes Payable, Current
Panacea Life Sciences Holdings, Inc. (PLSH) had Convertible Notes Payable, Current of $346.67 thousand as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2023-03-30
- 2022-12-31: Convertible Notes Payable, Current $346.67K.
- 2022-09-30: Convertible Notes Payable, Current $1.26M.
- 2022-06-30: Convertible Notes Payable, Current $947.59K.
- 2022-03-31: Convertible Notes Payable, Current $642.64K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2022-12-31 | $346.67K 10-K · filed 2023-03-30 | |
| 2022-09-30 | $1.26M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $947.59K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $642.64K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $220.00K 10-K · filed 2023-03-30 | |
| 2021-03-31 | $100.00K 10-Q/A · filed 2021-05-27 | |
| 2020-12-31 | $646.04K 10-Q/A · filed 2021-05-27 | $696.29K 10-K · filed 2021-04-15 |
| 2020-09-30 | $608.43K 10-Q · filed 2020-11-18 | |
| 2020-06-30 | $575.98K 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $402.21K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $85.91K 10-K/A · filed 2021-04-23 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $491.79K 10-K · filed 2020-05-22 | |
| 2018-09-30 | $345.64K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $259.94K 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $141.43K 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $57.80K 10-Q · filed 2018-11-14 | |
| 2017-09-30 | $14.01K 10-Q · filed 2017-11-20 | |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-20 |